I agree the news is going to be huge. The June 27 news was huge it got the share price out of pennyland. Company stated in last press release they will keep the shareholders updated with their requested Type A FDA meeting plan for submission Gimoti NDA.
Yes, company is re-submitting NEW DRUG APPLICATION. This time it will get FDA approval, because company has fix all the concerns in the CRL letter from the FDA.